Merck (NYSE: MRK) saw first-quarter revenue increase by 1% year-over-year. Woot! Not thrilling? What if I told you that the sales were negatively affected 1% from changes in foreign exchanges and decreased 2% because it stopped selling Remicade and Simponi in certain territories after a settlement with Johnson & Johnson (NYSE: JNJ). Excited now? No? Me neither.
Where does that leave investors? Sit and wait for better days. The patent cliff can't last forever, and Merck actually has a decent pipeline, so there's potential for growth, albeit with risk. Fortunately, unlike your typical biotech, where you'd have to wait for clinical trial results and regulatory approvals, Merck investors get paid a handsome 4.4% dividend while they wait. Dividend producers like Merck might not be the most exciting companies to own, but they can be worth it.
Source: Motley Fool
Related Articles:
- 7 Dividend Stocks Delivering The Secret To Successful Investing
- There's Gold In Them Thar Dividend Stocks
- Buy And Hold Is Not Buy And Forget
- 9 Dividend Stocks With A Low P/B Ratio
- 10 Dividend Stocks Beating the S&P With Positive Returns
Dividend Growth Stocks News
- Prediction: 5 Dividend Stocks That Could Crush the S&P 500 Over the Next 10 Years - MSN - 5/21/2025
- Prediction: These 3 Monster Dividend Stocks Will Continue Crushing the S&P 500 Beyond 2025 - The Globe and Mail - 5/21/2025
- 9 Cheap Dividend Stocks (All Under $11) - MSN - 5/21/2025
- 5 Top Dividend Stocks Yielding Over 5% to Buy for Passive Income - MSN - 5/21/2025
- 3 Dividend Stocks With Yields From 3.2% To 4.9% - Yahoo Finance - 5/21/2025
- Automatic Data Processing Inc. (ADP) Dividend Stock Analysis - 5/16/2025
- Air Products and Chemicals Inc. (APD) Dividend Stock Analysis - 5/9/2025
- Waste Management, Inc. (WM) Dividend Stock Analysis - 5/2/2025
- Wal-Mart Stores, Inc. (WMT) Dividend Stock Analysis - 4/25/2025
- Abbott Laboratories (ABT) Dividend Stock Analysis - 4/18/2025
An Unexcitingly Good Dividend Play
Posted by D4L | Wednesday, May 09, 2012 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.